H.B. Fuller arrives at its September 23 earnings print — due after the close today — with the stock clawing back some ground but options traders signalling the most defensive posture seen in months.
The price has partially recovered from the worst of September's damage. FUL closed at $51.07 on Tuesday, up 2.9% on the day and roughly flat on the week, but still down 13% over the past month. That is a meaningful improvement from the $50.89 close flagged in last week's note, and it puts the stock a fraction above the August lows. Peers moved similarly on the day — IOSP gained 3.8% and NGVT added 3.3% — so Tuesday's bounce was sector-wide rather than FUL-specific. The broader group is still nursing weekly losses, with AXTA and MTX both down slightly on the week, while managed a 2.7% weekly gain.
Options positioning is the clearest signal heading into tonight's print. The put/call ratio jumped to 1.14 on Tuesday — more than 2.7 standard deviations above its 20-day average of 0.18. That is a striking shift. For most of the past month, the PCR ran below 0.10, meaning calls overwhelmingly dominated open interest. That flipped sharply on September 21-22, with the ratio briefly touching 1.33 before settling at 1.14. The 52-week high is 6.24, so this is nowhere near panic territory, but the sudden turn toward puts is hard to read as anything other than demand for downside protection ahead of the result.
Short positioning has actually eased since last week's note, which is a notable change from the pattern described then. Short interest fell roughly 6% on the week to 5.1% of the free float — down from the 5.25% reading seven days ago, and pulling back from the September 10 peak of around 5.4%. Bears were adding into the month-long selloff; they are now trimming slightly as the stock stabilises. The borrow market remains entirely unstressed: availability has surged to 3,218% — more than doubling over the past week and far above the 52-week trough of 607%. Cost to borrow crept up 17% on the month to 0.53%, but that remains negligible in absolute terms. There is no mechanical squeeze pressure here.
The analyst community had been upgrading its view through late June — JP Morgan moved to Overweight, Citigroup and Deutsche Bank both raised targets to $75 and $72 respectively — leaving a consensus mean target near $73. That is a 43% premium to Tuesday's close. That gap is large enough to be meaningful, but this analyst data is nearly three months old and predates the stock's sharp September decline. Whether those targets survive tonight's print is the real question. The valuation is not demanding at a trailing P/E of 9.8x and EV/EBITDA of 6.8x — both compressed well below what the consensus target implies. The short score has drifted lower all week, from 43.4 on September 10 to 40.3 now, consistent with the modest short-covering underway.
The earnings history adds context without offering comfort. The June quarter result sent the stock down 2.1% on the day and 10.1% over the following five sessions. The April print was the exception — a 5% gain on the day — but that reversed quickly, with only a 2.8% gain after five days. Two of the last three prints produced negative five-day outcomes. Tonight's setup is therefore less about the beat-or-miss headline and more about whether management's commentary on end-market demand and margin trajectory can begin to close the gap between a $51 stock and a $73 consensus target — or whether another cautious outlook reinforces the bears who spent September building their position.
See the live data behind this article on ORTEX.
Open FUL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
